Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis.
Saved in:
| Title: | Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis. |
|---|---|
| Authors: | Devi R; ISF College of Pharmacy, Ferozepur GT Road, Moga, Punjab, 142001, India., Dadwal P; ISF College of Pharmacy, Ferozepur GT Road, Moga, Punjab, 142001, India., Sharma N; Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Uttar Pradesh, Sector-125, Noida, 201313, India., Singh A; Department of Pharmaceutics, ISF College of Pharmacy, Ferozepur GT Road, Moga, Punjab, 142001, India., Arora A; Department of Pharmaceutics, ISF College of Pharmacy, Ferozepur GT Road, Moga, Punjab, 142001, India. akshita1913@gmail.com. |
| Source: | Inflammopharmacology [Inflammopharmacology] 2026 Jul; Vol. 34 (7), pp. 4463-4481. Date of Electronic Publication: 2026 Jun 15. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1568-5608 (Electronic) Linking ISSN: 09254692 NLM ISO Abbreviation: Inflammopharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1568-5608 |
|---|---|
| DOI: | 10.1007/s10787-026-02284-5 |
